KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $178.2 million.

  • Charles River Laboratories International's Free Cash Flow fell 1634.43% to $178.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $543.7 million, marking a year-over-year decrease of 299.99%. This contributed to the annual value of $501.6 million for FY2024, which is 3728.82% up from last year.
  • Charles River Laboratories International's Free Cash Flow amounted to $178.2 million in Q3 2025, which was down 1634.43% from $169.3 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Free Cash Flow registered a high of $213.1 million during Q3 2024, and its lowest value of $2.5 million during Q2 2023.
  • Its 5-year average for Free Cash Flow is $113.4 million, with a median of $130.5 million in 2021.
  • As far as peak fluctuations go, Charles River Laboratories International's Free Cash Flow tumbled by 8868.54% in 2023, and later surged by 192328.55% in 2024.
  • Charles River Laboratories International's Free Cash Flow (Quarter) stood at $130.5 million in 2021, then increased by 11.69% to $145.7 million in 2022, then dropped by 2.14% to $142.6 million in 2023, then tumbled by 41.28% to $83.7 million in 2024, then skyrocketed by 112.84% to $178.2 million in 2025.
  • Its Free Cash Flow stands at $178.2 million for Q3 2025, versus $169.3 million for Q2 2025 and $112.4 million for Q1 2025.